Literature DB >> 29890370

Harnessing immune history to combat influenza viruses.

Jenna J Guthmiller1, Patrick C Wilson2.   

Abstract

Individuals are exposed to influenza viruses throughout their lifetime. Accumulating evidence shows the first viruses an individual is exposed to leaves an imprint on the antibody response induced by subsequent drifted and novel influenza viral exposures. Imprinted humoral immunity against influenza viruses relies on biased immune memory to influenza viruses for which memory B cell responses were initially generated against. Imprinting allows for antibodies to adapt to drifted influenza viruses while maintaining binding potential for the first influenza viruses an individual is exposed to. However, imprinting can increase susceptibility to non-imprinted influenza viruses and mismatched influenza viruses. This review highlights the role of imprinting on the regulation of antibody responses induced by influenza viruses and explores potential vaccine strategies to harness imprinted antibody responses to increase protection against influenza.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2018        PMID: 29890370     DOI: 10.1016/j.coi.2018.05.010

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  25 in total

1.  Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus.

Authors:  Maya Sangesland; Larance Ronsard; Samuel W Kazer; Julia Bals; Seyhan Boyoglu-Barnum; Ashraf S Yousif; Ralston Barnes; Jared Feldman; Maricel Quirindongo-Crespo; Patrick M McTamney; Daniel Rohrer; Nils Lonberg; Bryce Chackerian; Barney S Graham; Masaru Kanekiyo; Alex K Shalek; Daniel Lingwood
Journal:  Immunity       Date:  2019-09-25       Impact factor: 31.745

Review 2.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

3.  Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice.

Authors:  Angela Choi; Badiaa Bouzya; Klaus-Daniel Cortés Franco; Daniel Stadlbauer; Arvind Rajabhathor; Ronan N Rouxel; Roland Mainil; Marie Van der Wielen; Peter Palese; Adolfo García-Sastre; Bruce L Innis; Florian Krammer; Michael Schotsaert; Corey P Mallett; Raffael Nachbagauer
Journal:  Immunohorizons       Date:  2019-04-01

4.  Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans.

Authors:  Haley L Dugan; Jenna J Guthmiller; Philip Arevalo; Min Huang; Yao-Qing Chen; Karlynn E Neu; Carole Henry; Nai-Ying Zheng; Linda Yu-Ling Lan; Micah E Tepora; Olivia Stovicek; Dalia Bitar; Anna-Karin E Palm; Christopher T Stamper; Siriruk Changrob; Henry A Utset; Lynda Coughlan; Florian Krammer; Sarah Cobey; Patrick C Wilson
Journal:  Sci Transl Med       Date:  2020-12-09       Impact factor: 17.956

Review 5.  Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs.

Authors:  Santosh Dhakal; Sabra L Klein
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

6.  Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study.

Authors:  Carole Henry; Anna-Karin E Palm; Henry A Utset; Min Huang; Irvin Y Ho; Nai-Ying Zheng; Theresa Fitzgerald; Karlynn E Neu; Yao-Qing Chen; Florian Krammer; John J Treanor; Andrea J Sant; David J Topham; Patrick C Wilson
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

Review 7.  The human antibody response to influenza A virus infection and vaccination.

Authors:  Florian Krammer
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

8.  Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza Virus.

Authors:  Assaf Amitai; Maya Sangesland; Ralston M Barnes; Daniel Rohrer; Nils Lonberg; Daniel Lingwood; Arup K Chakraborty
Journal:  Cell Syst       Date:  2020-10-07       Impact factor: 10.304

Review 9.  Influenza immune escape under heterogeneous host immune histories.

Authors:  Rachel J Oidtman; Philip Arevalo; Qifang Bi; Lauren McGough; Christopher Joel Russo; Diana Vera Cruz; Marcos Costa Vieira; Katelyn M Gostic
Journal:  Trends Microbiol       Date:  2021-07-01       Impact factor: 17.079

Review 10.  The Future of Influenza Vaccines: A Historical and Clinical Perspective.

Authors:  Nicole M Bouvier
Journal:  Vaccines (Basel)       Date:  2018-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.